Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunotherapy: Activation, Suppression and Treatments
Tell A Friend
Tell someone you know about this product.
Immunotherapy: Activation, Suppression and Treatments
Retail Price: $265.00
10% Online Discount
You Pay:

Editors: Blake C. Facinelli
Book Description:
Immunotherapy is a medical term defined as "treatment of disease by inducing, enhancing, or suppressing an immune response". Immunotherapies are designed to elicit or amplify an immune response and are classified as activation immunotherapies. Immunotherapies designed to reduce, suppress or more appropriately direct an existing immune response, as in cases of autoimmunity or allergy, are classified as suppression immunotherapies. This new book reviews research on immunotherapies including antifungal immunotherapy; active and specific immunotherapeutical strategies for the prevention and treatment of cancer; allergen immunotherapy; dendritic cell/tumor fusion cell vaccine in cancer therapy and CRLA-4 inhibition in malignant melanoma.

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:

Chapter 1. Antifungal Immunotherapy: A Reality Check, pp. 1-76
(Mawieh Hamad, Khaled Abu-Elteen, JMS Medicals, Amman, Jordan, and Hashemite University, Zarqa, Jordan)

Chapter 2. Cancer: Recent Development of Cell-Based Immunotherapy, pp. 77-129
(Amedeo Amedei, Mario Milco D’Elios, University of Florence, Florence, Italy, and others)

Chapter 3. Allergen Immunotherapy: Current Approaches for Management of Allergic Rhinitis and Asthma, pp. 131-157
(Naveen Arora, Neetu Kukreja, Smitha Nair, S.N. Gaur, B.P. Singh, Institute of Genomics and Integrative Biology (CSIR), Delhi, India, and others)

Chapter 4. Dendritic Cell/Tumor Fusion Cell Vaccine in Cancer Therapy, pp. 159-174
(Jia-Ming Chang, Yi-Ru Lee, Kai-ling Huang, Development Center for Biotechnology, Taipei County, Taiwan, ROC, and others)

Chapter 5. CTLA-4 Inhibition in Malignant Melanoma: A New Promising Immunotherapy Target, pp. 175-180
(Tanguy Metz, Wolfram Fink and Pierre Vereecken, Department of Dermatology, CHU-Brugmann, Brussels, Belgium)

Chapter 6. Immunotherapy with IG-Derived Peptides in Systemic Lupus Erythematosus, pp. 181-200
(Antonio La Cava,Division of Rheumatology, Dept. of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California)

Chapter 7. Cancer Immunotherapy and Tumor Escape, pp. 201-221
(Masoud H. Manjili, Maciej Kmieciak, VCU Massey Cancer Center, Commonwealth Foundation for Cancer Research)*


      Immunology and Immune System Disorders
   Binding: Hardcover
   Pub. Date: 2010
   Pages: 7 x 10
   ISBN: 978-1-61668-585-0
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Immunotherapy: Activation, Suppression and Treatments